Skip to main content
OpenTrials
Completed

NCT Number: NCT02285426

HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study

Videobronchoscopy is an essential diagnostic procedure for evaluation of the central airways and pivotal for the diagnosis and staging of lung cancer. Further technological improvements have resulted in high definition (HD+) images and advanced image enhancement technique (i-scan). An earlier study (NCT01676012) has indicated that HD+ bronchoscopy in combination with i-scan technology is superior to HD+WL (white light) for detecting endobronchial vascular changes. In this study we aim to correlate these vascular changes to histology and hypothesize that these vascular changes are related to (pre-) malignant changes and that the addition of i-scan is superior to HD+ WL.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ospedale Umberto I, Via Dante Alighieri n.1, Ravenna, RA, Italy

Loading trial locations.

About this study

Patients will undergo a bronchoscopy with Pentax EB1990i HD-bronchoscope in combination with Pentax EPKi series videoprocessor investigating the entire bronchial tree. Bronchoscopy will be performed by an experienced chest physician under local anaesthesia use and type of sedation following local protocol. Bronchoscopy will be performed in a standardized order using three different imaging modes. The order of the different modes will be randomized to avoid induced scope and / or cough lesion bias. High definition digital videos will be made from all procedures without in screen patient identification, but using a study code. The three imaging modes used in this study are: HD+, HD+ surface enhancement (SE, i-scan1) and HD+ surface enhancement and tone enhancement (TE-c, i-scan2).

When sites with abnormal or suspicious vascular patterns are detected the investigator grade these findings using a visual classification scale [adapted from Herth JTO 2009 & Zaric Med Oncol 2013] and change to a regular bronchoscope and take biopsies from each site and a biopsy from a normal secondary carina on the contralateral site as control. Finally any other indicated procedures will be performed at the discretion of the local investigator.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with indication for diagnostic bronchoscopy for suspected or proven lung cancer.
  • ASA physical status 1-3.
  • Age 18 years or older.
  • Signed and dated patient informed consent.

Exclusion criteria

  • Bleeding disorders.
  • Indication for use of anticoagulant therapy (acenocoumarol, warfarin, therapeutic dose of low molecular weight heparines or clopidrogel).
  • Known allergy for lidocaine.
  • Known pulmonary hypertension.
  • Recent and/or uncontrolled cardiac disease.
  • Compromised upper airway (eg concomitant head and neck cancer or central airway stenosis for any reason).
  • ASA classification greater than or equal to 4.
  • Pregnancy.
  • Inability to consent.

Treatment and study plan

Pentax EB-1990i HD-bronchoscope guided biopsy

Device

3 different types of bronchoscopy image settings will be used investigating the entire bronchial tree.

When sites with abnormal or suspicious vascular patterns are detected meeting the criteria of abnormality [visual scale adapted from Herth 2009 and Zaric 2013] the investigator will change to a normal bronchoscope and take biopsies from each site and a biopsy from a normal secondary carina on the contralateral site as control.

Primary outcomes

  1. positive predictive value of HD+ i-scan bronchoscopy for detecting (pre-) malignant lesions

    Time frame: 7 days

    Determing the positive predictive value of HD+ i-scan bronchoscopy for vascular pattern detection .

Secondary outcomes

  1. correlation between endobronchial vascular patterns and histology

    Time frame: 7 days

    relate grading of detected vascular abnormalities with histology outcome of biopsies

  2. interobserver variability for detecting vascular abnormalities

    Time frame: 3 - 12 months

    compare bronchoscopist reported outcome to central review of obtained videos to determine interobserver variability

  3. impact of HD-bronchoscopy on clinical decision

    Time frame: 1-56 days

    interview based evaluation to investigate whether the use of of i-scan technology and or the outcome of study-detected vascular sites changed the clinical approach or follow-up plan

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Registry information

Official study title

A Multicenter Study Evaluating the Diagnostic Value for Vascular Abnormalities of High Definition Bronchoscopy When Combined With I-scan Imaging Technology Compared to High Defintion Bronchoscopy Alone

Acronym: i-scan

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Nov 7, 2014
Registry last updated
Apr 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.